Trinity Biotech to Announce Q2 2024 Resultsby Lilu Anderson 14.08.2024Trinity Biotech will release its Q2 2024 financial results on August 14, 2024, with a call at 8:30 AM ET ...
Legend Biotech’s Q2 2024 Earnings: Growth & Strategyby Lilu Anderson 12.08.2024Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
InspireMD Eyes US Launch Amid Revenue Growthby Mark Eisenberg 11.08.2024InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
ATSG Sees Growth, Raises 2024 EBITDA Outlookby Mark Eisenberg 11.08.2024ATSG reports strong Q2 2024 growth, raises EBITDA outlook, expands Amazon partnership with more aircraft.
Nikola Reports Q2 Progress in Hydrogen Expansionby Mark Eisenberg 11.08.2024Nikola Corp sees growth in hydrogen trucks, reports losses. Aiming for 14 fuel stations in North America by end of ...
EIC’s Strong Q2 2024 Boosted by Aerospace Growthby Mark Eisenberg 11.08.2024Exchange Income Corporation reports robust Q2 2024 results, driven by aerospace and aviation. Strategic growth bolstered by key acquisitions.
Chartwell Retirement Residences Reports Strong Q2 Growthby Mark Eisenberg 10.08.2024Chartwell achieved robust Q2 financial results, expanding occupancy and operating margin, with strategic acquisitions in Quebec.
Aura Minerals Projects Robust Growth Amid Challengesby Mark Eisenberg 10.08.2024Aura Minerals reports Q2 insights, highlighting strategic growth plans with Borborema project progress.
Roivant’s Growth and Clinical Progress in Q1 2024by Mark Eisenberg 10.08.2024Roivant reports strong clinical progress, with significant Phase 3 study completions, revenue growth, and financial strength.
New Fortress Energy’s Q2 2024 Earnings Reviewby Mark Eisenberg 10.08.2024New Fortress Energy reports lower than expected Q2 2024 earnings. FLNG 1 operational, promising $500 million annual boost.